Is AbbVie (ABBV) Still Attractive After A 21.5% One Year Share Price Gain?
- If you are wondering whether AbbVie stock still offers value after a strong run, it is important to see how different valuation methods line up against the current share price.
- The stock recently closed at US$215.40, with returns of 1.5% over the past week, 9.1% over the past month, and 21.5% over the past year, while year to date it is down 6.1%.
- Recent coverage has focused on AbbVie’s position in the large cap pharmaceuticals and biotech space and how investors weigh long term drug pipelines and patent cycles against pricing and regulatory questions. This context helps explain why the stock’s moves can be sharp at times, as sentiment shifts around the durability and quality of future cash flows.
- On Simply Wall St’s valuation checks,…
Source link
